Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly (IRIDIA)

This study has been terminated.

(End of recruitment period)

Sponsor:

Information provided by:

Assistance Publique - Hôpitaux de Paris

ClinicalTrials.gov Identifier:

NCT00224575

First received: September 13, 2005

Last updated: September 29, 2009

Last verified: April 2008

History of Changes

Tracking Information

First Received Date ^ICMJE

September 13, 2005

Last Updated Date

September 29, 2009

Start Date ^ICMJE

November 2004

Primary Completion Date

November 2005 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly [ Time Frame: during hospitalization ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

to evaluate the therapeutical impact of a reassessment strategy in the diagnosis of coronary heart disease in elderly

Change History

Complete list of historical versions of study NCT00224575 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

part link, in the treatment modification, with diagnosis reassessment and the part link with treatment optimization, death and rehospitalization in the subsequent 6 and 12 months [ Time Frame: during hospitalization ] [ Designated as safety issue: Yes ]

Original Secondary Outcome Measures ^ICMJE

to determine in the treatment modification the part link with diagnosis reassessment and the part link with treatment optimization

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly

Official Title ^ICMJE

Therapeutical Impact of a Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly

Brief Summary

Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease, this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment.

in a first time, diagnosis reassessment with invasive technique if necessary. in a second time, treatment reassessment.

Detailed Description

not desired

Study Type ^ICMJE

Interventional

Study Phase

Not Provided

Study Design ^ICMJE

Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic

Condition ^ICMJE

Myocardial Ischemia

Intervention ^ICMJE

Other: diagnosis reassessment
Strategy of diagnosis reassessment following a decision tree.

Other Name: no other names to specified
Other: Diagnosis strategy and subsequent therapeutic reassessment
Performed by geriatricians, following a decision tree, based on medical history, electrocardiogram, cardiac echotomography and stress scintigraphy

Study Arm (s)

Experimental: 1

All patients are in that arms. They all receive the diagnosis reassessment strategy.

Interventions:

Other: diagnosis reassessment
Other: Diagnosis strategy and subsequent therapeutic reassessment

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Terminated

Enrollment ^ICMJE

260

Completion Date

November 2006

Primary Completion Date

November 2005 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

patients 75 of age or older hospitalized in a geriatric service and suspect of coronary heart disease

Exclusion Criteria:

acute myocardial infarction

Gender

Both

Ages

75 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

France

Administrative Information

NCT Number ^ICMJE

NCT00224575

Other Study ID Numbers ^ICMJE

AOM03099

Has Data Monitoring Committee

Responsible Party

Zakia IDIR, Department Clinical Rechearch of Developpement

Study Sponsor ^ICMJE

Assistance Publique - Hôpitaux de Paris

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

legrain sylvie

APHP

Information Provided By

Assistance Publique - Hôpitaux de Paris

Verification Date

April 2008

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top